Velan Capital Investment Management LP
49 holdingsFiling period: 2026-03-31Current AUM: $143.4Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | 100.8K | $32.5M | $31.0M | 21.64% | -- | 2026-03-31 |
| 2 | TARA | PROTARA THERAPEUTICS INC | 2.83M | $14.8M | $11.1M | 7.75% | -- | 2026-03-31 |
| 3 | STRO | SUTRO BIOPHARMA INC | 512.2K | $12.8M | $12.4M | 8.63% | +200.2K | 2026-03-31 |
| 4 | EVMN | EVOMMUNE INC | 446.3K | $10.3M | $5.0M | 3.50% | -60,499 | 2026-03-31 |
| 5 | MPLT | MAPLIGHT THERAPEUTICS INC | 492.9K | $10.0M | $6.4M | 4.48% | -29,412 | 2026-03-31 |
| 6 | TENX | TENAX THERAPEUTICS INC | 583.3K | $9.3M | $8.0M | 5.57% | +500.0K | 2026-03-31 |
| 7 | ABVX | ABIVAX SA | 77.0K | $8.6M | $9.6M | 6.71% | +10.0K | 2026-03-31 |
| 8 | HRTX | HERON THERAPEUTICS INC | 8.75M | $7.0M | $4.3M | 3.03% | -- | 2026-03-31 |
| 9 | IMMX | IMMIX BIOPHARMA INC | 740.0K | $6.7M | $6.2M | 4.29% | +705.0K | 2026-03-31 |
| 10 | ESPR | ESPERION THERAPEUTICS INC NE | 1.72M | $4.7M | $4.7M | 3.29% | +510.0K | 2026-03-31 |
| 11 | EDSA | EDESA BIOTECH INC | 827.5K | $4.3M | $4.2M | 2.95% | +140.0K | 2026-03-31 |
| 12 | AVR | ANTERIS TECHNOLOGIES GLOBAL | 700.0K | $3.9M | $5.5M | 3.83% | -- | 2026-03-31 |
| 13 | NSPR | INSPIREMD INC | 2.10M | $3.4M | $1.4M | 0.95% | -44,046 | 2026-03-31 |
| 14 | XNCR | XENCOR INC | 250.0K | $3.0M | $5.1M | 3.52% | -- | 2026-03-31 |
| 15 | AVTX | AVALO THERAPEUTICS INC | 185.1K | $2.8M | $3.4M | 2.36% | -78,520 | 2026-03-31 |
| 16 | EPRX | EUPRAXIA PHARMACEUTICALS INC | 352.0K | $2.5M | $2.3M | 1.57% | -- | 2026-03-31 |
| 17 | CTMX | CYTOMX THERAPEUTICS INC. | 540.0K | $2.5M | $1.7M | 1.17% | +460.0K | 2026-03-31 |
| 18 | VRCA | VERRICA PHARMACEUTICALS INC | 471.6K | $2.5M | $2.5M | 1.72% | -- | 2026-03-31 |
| 19 | JSPR | JASPER THERAPEUTICS INC | 2.67M | $2.3M | $1.7M | 1.17% | -- | 2026-03-31 |
| 20 | RZLT | REZOLUTE INC | 750.0K | $2.3M | $3.5M | 2.47% | -- | 2026-03-31 |
| 21 | LYEL | LYELL IMMUNOPHARMA INC | 102.0K | $2.0M | $1.3M | 0.92% | -- | 2026-03-31 |
| 22 | PROF | PROFOUND MED CORP | 285.7K | $1.9M | $2.1M | 1.47% | -- | 2026-03-31 |
| 23 | VRDN | VIRIDIAN THERAPEUTICS INC | 91.1K | $1.8M | $1.7M | 1.20% | +4.6K | 2026-03-31 |
| 24 | RCKT | ROCKET PHARMACEUTICALS INC | 294.6K | $1.1M | $916K | 0.64% | -- | 2026-03-31 |
| 25 | KZIA | KAZIA THERAPEUTICS LTD | 135.3K | $1.0M | $1.7M | 1.19% | -164,685 | 2026-03-31 |
← Scroll →
Page 1 of 2